- Home
- SGMO vs ACTG Comparison
SGMO vs ACTG Comparison
Compare SGMO & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- ACTG
- Stock Information
- Founded
- SGMO 1995
- ACTG 1993
- Country
- SGMO United States
- ACTG United States
- Employees
- SGMO N/A
- ACTG N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- ACTG Multi-Sector Companies
- Sector
- SGMO Health Care
- ACTG Miscellaneous
- Exchange
- SGMO Nasdaq
- ACTG Nasdaq
- Market Cap
- SGMO 488.2M
- ACTG 414.8M
- IPO Year
- SGMO 2000
- ACTG 1996
- Fundamental
- Price
- SGMO $1.13
- ACTG $4.44
- Analyst Decision
- SGMO Buy
- ACTG Strong Buy
- Analyst Count
- SGMO 5
- ACTG 1
- Target Price
- SGMO $5.20
- ACTG $7.00
- AVG Volume (30 Days)
- SGMO 10.5M
- ACTG 203.4K
- Earning Date
- SGMO 03-12-2025
- ACTG 03-13-2025
- Dividend Yield
- SGMO N/A
- ACTG N/A
- EPS Growth
- SGMO N/A
- ACTG N/A
- EPS
- SGMO N/A
- ACTG 0.39
- Revenue
- SGMO $52,291,000.00
- ACTG $165,779,000.00
- Revenue This Year
- SGMO N/A
- ACTG N/A
- Revenue Next Year
- SGMO $5.97
- ACTG $84.79
- P/E Ratio
- SGMO N/A
- ACTG $11.39
- Revenue Growth
- SGMO N/A
- ACTG 261.08
- 52 Week Low
- SGMO $0.30
- ACTG $3.78
- 52 Week High
- SGMO $3.18
- ACTG $5.74
- Technical
- Relative Strength Index (RSI)
- SGMO 37.01
- ACTG 54.57
- Support Level
- SGMO $1.00
- ACTG $4.31
- Resistance Level
- SGMO $1.18
- ACTG $4.44
- Average True Range (ATR)
- SGMO 0.15
- ACTG 0.10
- MACD
- SGMO -0.04
- ACTG 0.02
- Stochastic Oscillator
- SGMO 13.84
- ACTG 87.50
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.